QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=EA1FF0D9E26D262197E6237452B385B3;jsessionid=8B0AD74FF1A141907FE50F7191CD50A7;jsessionid=66EFD9001A72E8FEE9D17DF0891DF22F;jsessionid=13001AF29F3CD92E71F6BF359BBE1614;jsessionid=213B35AE05645B69FEBFBE349F290D7A;jsessionid=0B0BB7434F8EAC21736657C288D8B6EB (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=EA1FF0D9E26D262197E6237452B385B3;jsessionid=8B0AD74FF1A141907FE50F7191CD50A7;jsessionid=66EFD9001A72E8FEE9D17DF0891DF22F;jsessionid=13001AF29F3CD92E71F6BF359BBE1614;jsessionid=213B35AE05645B69FEBFBE349F290D7A;jsessionid=0B0BB7434F8EAC21736657C288D8B6EB